VEGFA and retinal vascular disorder: Intravitreal anti-vascular endothelial growth factor (VEGF) injections are the current standard of care for choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) and retinal vascular disorders, both sight-threatening diabetic macular oedema (DME) and retinal vein occlusion (RVO) with cystoid macular oedema (CME) [1–4].